scholarly journals Cost Utility Analysis of a Pilot Study for the Korean Lung Cancer Screening Project

2021 ◽  
Author(s):  
Juyoung Kim ◽  
Bogeum Cho ◽  
Seon-Ha Kim ◽  
Chang-Min Choi ◽  
Yeol Kim ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Screening ◽  
Pilot Study ◽  
Lung Cancer Screening ◽  
Cost Utility ◽  
Cost Utility Analysis ◽  
Utility Analysis

scholarly journals A Cost-Utility Analysis of Lung Cancer Screening and the Additional Benefits of Incorporating Smoking Cessation Interventions

PLoS ONE ◽  
2013 ◽  
Vol 8 (8) ◽  
pp. e71379 ◽  
Author(s):  
Andrea C. Villanti ◽  
Yiding Jiang ◽  
David B. Abrams ◽  
Bruce S. Pyenson
Keyword(s):  
Lung Cancer ◽  
Smoking Cessation ◽  
Cancer Screening ◽  
Lung Cancer Screening ◽  
Cost Utility ◽  
Cost Utility Analysis ◽  
Utility Analysis

scholarly journals Retrospective assessment of Lung-RADS® performance in the Silesian Lung Cancer Screening Pilot Study

2020 ◽  
Vol 16 (2) ◽  
pp. 52-55
Author(s):  
Ewa Wachuła ◽  
Sylwia Szabłowska-Siwik ◽  
Damian Czyżewski ◽  
Jerzy Kozielski ◽  
Wojciech Rogowski ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Screening ◽  
Pilot Study ◽  
Lung Cancer Screening ◽  
Retrospective Assessment

scholarly journals Ten years of experience in lung cancer screening in Gdańsk, Poland: a comparative study of the evaluation and surgical treatment of 14 200 participants of 2 lung cancer screening programmes

2019 ◽  
Vol 29 (2) ◽  
pp. 266-274 ◽  
Author(s):  
Marcin Ostrowski ◽  
Tomasz Marjański ◽  
Robert Dziedzic ◽  
Małgorzata Jelitto-Górska ◽  
Katarzyna Dziadziuszko ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Screening ◽  
Pilot Study ◽  
Low Dose ◽  
Screening Programme ◽  
Lung Cancer Screening ◽  
Smoking History ◽  
Diagnostic Work ◽  
Low Dose Computed Tomography ◽  
Tomography Scan

Abstract OBJECTIVES The European Society of Thoracic Surgeons’ recommendations confirm the implementation of lung cancer screening in Europe. We compared 2 screening programmes, the Pilot Pomeranian Lung Cancer Screening Programme (pilot study) and the Moltest Bis programme, completed in a single centre. METHODS A total of 8649 healthy volunteers (aged 50–75 years, smoking history ≥20 pack-years) were enrolled in a pilot study between 2009 and 2011, and a total of 5534 healthy volunteers (aged 50–79, smoking history ≥30 pack-years) were enrolled in the Moltest Bis programme between 2016 and 2017. Each participant had a low-dose computed tomography scan of the chest. Participants with a nodule diameter of >10 mm or with suspected tumour morphology underwent a diagnostic work-up in the pilot study. In the Moltest Bis programme, the criteria were based on the volume of the detected nodule on the baseline low-dose computed tomography scan and the volume doubling time in the subsequent rounds. RESULTS Lung cancer was diagnosed in 107 (1.24%) and 105 (1.90%) participants of the pilot study and of the Moltest Bis programme, respectively (P = 0.002). A total of 300 (3.5%) and 199 (3.6%) patients, respectively, were referred for further invasive diagnostic work-ups (P = 0.69). A total of 125 (1.5%) and 80 (1.5%) patients, respectively, underwent surgical resection (P = 0.74). The number of resected benign lesions was similar: 44 (35.0%) and 20 (25.0%), respectively (P = 0.13), but with a downwards trend. Lobectomies and/or segmentectomies were performed in 84.0% and 90.0% of patients with lung cancer, respectively (P = 0.22). Notably, patients in the Moltest Bis programme underwent video-assisted thoracoscopic surgery more often than did those in the pilot study (72.5% vs 24.0%, P < 0.001). Surgical patients with stages I and II non-small-cell lung cancer (NSCLC) accounted for 83.4% of the Moltest patients and 86.4% of the pilot study patients (P = 0.44). CONCLUSIONS Modified inclusion criteria in the screening programme lead to a higher detection rate of NSCLC. Growing expertise in lung cancer screening leads to increased indications for minimally invasive surgery and an increased proportion of lung-sparing resections. A single-team experience in lung cancer screening does not lead to a major reduction in the rate of diagnostic procedures and operations for non-malignant lesions.

scholarly journals A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines

2015 ◽  
Vol 15 (1) ◽  
Author(s):  
Anna Melissa Guerrero ◽  
Anne Julienne Genuino ◽  
Melanie Santillan ◽  
Naiyana Praditsitthikorn ◽  
Varit Chantarastapornchit ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Human Papillomavirus ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
The Philippines ◽  
Cost Utility ◽  
Cost Utility Analysis ◽  
Utility Analysis ◽  
Human Papillomavirus Vaccination

scholarly journals Panel of serum metabolites discriminates cancer patients and healthy participants of lung cancer screening - a pilot study

2017 ◽  
Vol 64 (3) ◽  
pp. 513-518 ◽  
Author(s):  
Małgorzata Roś-Mazurczyk ◽  
Anna Wojakowska ◽  
Łukasz Marczak ◽  
Krzysztof Polański ◽  
Monika Pietrowska ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Screening ◽  
Pilot Study ◽  
Cancer Patients ◽  
Lung Cancer Screening ◽  
Serum Metabolites ◽  
Healthy Participants
Sign in / Sign up

Export Citation Format

Share Document